Patients with multiple myeloma face the highest relative risk of a heart attack within one year of a cancer diagnosis, according to a nationwide Danish study published in the International Journal of Cardiology.
Researchers analyzed 660,531 adults diagnosed with cancer between 2000 and 2023 to determine how cardiovascular outcomes vary across 13 different cancer subtypes.
While findings show distinct variations in risk, the standardized absolute risk for a myocardial infarction (MI) remained below 1% for all cancer groups.
Multiple myeloma patients carried an absolute risk of 0.91%, compared to 0.86% for bladder cancer and 0.72% for kidney cancer.
The study used patients with low-risk skin tumors as a reference group to calculate relative risk. Multiple myeloma was associated with a relative risk of 1.80, while bladder, kidney, leukemia, and gastrointestinal cancers also showed elevated figures.
| Cancer Subtype | Relative MI Risk |
|---|---|
| Multiple Myeloma | 1.80 |
| Bladder | 1.52 |
| Kidney | 1.51 |
| Leukemia | 1.45 |
| Gastrointestinal | 1.37 |
Interpreting these results requires accounting for competing mortality, as one-year death rates ranged from 2.2% in the skin tumor reference group to 71.9% for patients with hepatobiliary and pancreatic cancer. Because of these high mortality rates, the authors said that a low observed incidence of heart attacks does not necessarily reflect lower cardiovascular susceptibility.
The research did not establish that cancer subtypes directly cause the observed differences in heart attack risk.
The authors characterized the results as hypothesis-generating, noting that the study lacked consistent data on specific treatment regimens and lifestyle factors.
“The findings describe differences in early MI risk across cancer populations but do not establish that cancer subtype itself causes those differences,” the authors said.